SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-015203
Filing Date
2024-02-14
Accepted
2024-02-14 16:05:22
Documents
2
Period of Report
2024-02-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1597
2 EX-24 vrdn-ex24.htm EX-24 10142
  Complete submission text file 0000950170-24-015203.txt   13546
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Issuer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1215
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address
Tousignant Jennifer (Reporting) CIK: 0002010978 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36483 | Film No.: 24637725